Use of interleukin-4 antagonists and compositions thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61P 19/02 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2409267

Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.

L'invention concerne des procédés relatifs au traitement d'affections induites par l'IL-4, qui consistent à administrer aux patients des antagonistes vis-à-vis de l'IL-4. On peut citer comme antagonistes appropriés, entre autres, les récepteurs de l'IL-4 (du type IL-4R soluble humain), les anticorps qui se lient à l'IL-4, les anticorps qui se lient à l'IL-4R, les mutéines de l'IL-4 qui se lient à l'IL-4R mais sans induire de réponse biologique, les molécules qui inhibent la transduction des signaux correspondant à l'IL-4, et d'autres composés inhibant un effet biologique qui résulte de la liaison entre l'IL-4 et un IL-4R de surface cellulaire. Parmi les anticorps décrits figurent les anticorps monoclonaux humains résultant de procédures qui consistent à immuniser des souris transgéniques. On peut mobiliser ce type d'anticorps contre l'IL-4R. Certains des anticorps considérés inhibent à la fois les activités biologiques induites par l'IL-4 et par l'IL-3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of interleukin-4 antagonists and compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of interleukin-4 antagonists and compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-4 antagonists and compositions thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1615199

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.